Crosstalk between mitochondrial dysfunction and benign prostatic hyperplasia: unraveling the intrinsic mechanisms
Authors:
Open Access
- 1 January 2025
- journal article
- review article
- Published by Tech Science Press in Canadian Journal of Urology
- Vol. 32 (4) , 255-269
Abstract
Benign prostatic hyperplasia (BPH) represents a prevalent etiology of lower urinary tract symptoms (LUTS) in the male population, clinically defined by a non-malignant proliferation of prostatic tissue. While BPH exhibits a high prevalence among older male populations globally, the precise underlying mechanisms contributing to its development remain incompletely elucidated. Mitochondria, essential organelles within eukaryotic cells, are critical for cellular bioenergetics, the regulation of reactive oxygen species (ROS) generation, and the modulation of cell death pathways. The maintenance of mitochondrial homeostasis involves a complex interplay of processes. By synthesizing previous literature, this review discusses mitochondrial homeostasis in prostate glands and the role of mitochondrial dysfunction in the context of BPH. Furthermore, the review delved into each dimension of mitochondrial dysfunction in the specific etiology of BPH, highlighting its impact on cell survival, apoptosis, ferroptosis, oxidative stress and androgen receptor (AR). Overall, this review aims to unveil the crosstalk between mitochondrial dysfunction and BPH and identify intrinsic mechanisms.Keywords
This publication has 131 references indexed in Scilit:
- Heat Shock Protein Family A Member 1A Attenuates Apoptosis and Oxidative Stress via ERK/JNK Pathway in Hyperplastic ProstateMedcomm, 2025
- 5‐Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasiaThe Journal of Pathology, 2022
- Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial–mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathwayThe Prostate, 2021
- SIRT3 affects mitochondrial metabolic reprogramming via the AMPK–PGC‐1α axis in the development of benign prostatic hyperplasiaThe Prostate, 2021
- Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?The Prostate, 2021
- Mitochondrial biogenesis in neurodegenerationJournal of Neuroscience Research, 2017
- Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblastsThe Prostate, 2011
- Altered prostate epithelial development and IGF‐1 signal in mice lacking the androgen receptor in stromal smooth muscle cellsThe Prostate, 2010
- Medical management of benign prostatic hyperplasia with androgen suppressionThe Prostate, 1990
- Prostate epithelial cells utilize glucose and aspartate as the carbon sources for net citrate productionThe Prostate, 1989